Welcome to our dedicated page for Cellebrite Di news (Ticker: CLBTW), a resource for investors and traders seeking the latest updates and insights on Cellebrite Di stock.
Cellebrite Di Ltd (NASDAQ: CLBTW) delivers critical Digital Intelligence solutions for modern investigative challenges. This news hub provides stakeholders with essential updates about the company’s technological advancements, regulatory compliance, and market positioning.
Access consolidated information on product launches, partnership announcements, and financial disclosures relevant to CLBTW’s role in digital forensics and corporate investigations. Our curated collection serves investors and professionals needing to monitor developments in SaaS-based investigative tools, eDiscovery innovations, and cybersecurity capabilities.
Key updates include earnings reports, leadership changes, and technology patents across Cellebrite’s Case-to-Closure platform. All content undergoes strict verification to ensure accuracy and relevance for decision-makers in both public sector and corporate environments.
Bookmark this page for streamlined access to CLBTW’s latest developments in legally compliant data analysis solutions. Regularly updated to reflect the company’s progress in addressing evolving digital security demands.
Cellebrite DI Ltd. (Nasdaq: CLBT) has launched the Cellebrite Physical Analyzer Ultra Series and a SaaS-based Cellebrite Premium, enhancing their digital investigation capabilities. The PA Ultra Series processes larger volumes of data more efficiently, enabling quicker case resolution and supporting cryptocurrency data enrichment. The SaaS version offers a comprehensive cloud-based solution for data management in investigations. These innovations solidify Cellebrite's position as a leader in Digital Intelligence solutions for public and private sectors.
Cellebrite (NASDAQ: CLBT) reported a strong Q1 2022 with revenue of $62.4 million, marking a 17% increase year-over-year, and Annual Recurring Revenue (ARR) of $201 million, up 33%. The company's subscription revenue reached $48.2 million, reflecting a 19% growth. Cellebrite reiterated its 2022 outlook, expecting revenue between $285-300 million, representing 16-22% growth. The positive business environment is attributed to rising investments in Digital Intelligence solutions, and recent partnerships aim to enhance their offerings. GAAP net income stood at $55.4 million.
Cellebrite DI Ltd. (NASDAQ: CLBT) announced the launch of its cloud-based Cellebrite Premium service, aimed at enhancing access capabilities for law enforcement agencies. This SaaS version offers cost-effective licensing, reduces hardware needs, and provides timely updates for digital investigations. The offering will be showcased at the Techno Security & Digital Forensics Conference from May 9-12, 2022. Ronnen Armon, Chief Products & Technologies Officer, emphasized the importance of equipping agencies to manage increasing digital evidence.
Cellebrite DI Ltd. (NASDAQ: CLBT) has been recognized as a Leader in the IDC MarketScape: Worldwide Digital Forensics in Public Safety 2022 Vendor Assessment. The report evaluated six vendors on 11 core capabilities, highlighting Cellebrite's significant R&D investment, unmatched device support, and user-friendly technology. Customers praised its cloud delivery models and IP in visual analytics. The recognition underscores the importance of Cellebrite's solutions in modern law enforcement investigations, reflecting its commitment to innovation in digital intelligence.
Cellebrite (Nasdaq: CLBT) announced a USD 2 million agreement with a national police force in EMEA to enhance its digital intelligence capabilities, deploying over 100 UFED end point licenses. This expansion marks one of the largest Cellebrite Premium Enterprise deployments, aimed at reducing case backlogs and improving investigative efficiency. Arthur Veinstein, General Manager of International Business, noted that this modernization effort will foster better collaboration among examiners and investigators.
Cellebrite (Nasdaq: CLBT) announced it will report Q1 2022 financial results on May 12, 2022, before market open. A conference call is scheduled for 8:30 AM ET to discuss the results. Cellebrite specializes in Digital Intelligence solutions, significantly aiding public and private sector investigations. The company aims to enhance data management processes for legally sanctioned investigations, establishing itself as a trusted provider globally.
Cellebrite (Nasdaq: CLBT) announced an expanded partnership with a major U.S. sheriff’s office, enhancing digital evidence capabilities for investigations into violent crimes and internet crimes against children. This multi-year agreement, generating revenue of approximately USD 700,000 since 2021, includes access to Cellebrite's comprehensive Digital Intelligence platform. Alon Klomek, Chief Business Officer, emphasized the importance of these solutions for law enforcement in speeding up investigations. The company remains committed to improving public safety through advanced technology.
Cellebrite, a leader in Digital Intelligence (DI) solutions, has secured a multi-year agreement valued at over USD $800,000 with a state department of public safety in the U.S. This partnership aims to enhance investigative capabilities for law enforcement agencies and drug task forces through advanced data extraction and analysis from digital devices. The agreement reinforces Cellebrite's commitment to aiding law enforcement in addressing narcotic and opioid-related crimes, ultimately contributing to community safety.
Cellebrite DI Ltd. (Nasdaq: CLBT) has appointed Dr. Guy Rotkopf, former Director General of the Israel Ministry of Justice, as the new Chairperson of its Ethics & Integrity Committee. This committee, established in 2021, guides the board on international law and ethical practices concerning the use of Cellebrite's technologies. Dr. Rotkopf holds a PH.D. in law and aims to enhance ethical standards in the company’s operations. The committee comprises eight members with diverse backgrounds in human rights and technology, reinforcing Cellebrite's dedication to responsible business practices.
Cellebrite (Nasdaq: CLBT) announced a multi-year agreement worth over $2.5 million with a national police agency in the Asia-Pacific region. This engagement will expand the deployment of Cellebrite’s Digital Intelligence (DI) solutions to assist in reducing crime and enhancing public safety. This contract extends their long-term relationship, reinforcing Cellebrite's reputation and impact in law enforcement. The deployment aims to support digital transformation within government agencies, bolstering safety measures through advanced investigative tools.
FAQ
What is the current stock price of Cellebrite Di (CLBTW)?
